Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02571036
Title A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Deciphera Pharmaceuticals LLC
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

Ripretinib

Age Groups: adult
Covered Countries USA | ITA | DEU | CAN


No variant requirements are available.